US$ 27.03
glp-1 drugs and fatty liver Why are agonists being used to treat patients with nonalcoholic disease? The Role of GLP1-RAs in
Description
Only Wegovy (semaglutide) is FDA-approved specifically for weight management in people without diabetes

Glycaemic control typically improves within the first few weeks, whilst significant weight loss and associated energy improvements may take 3-6 months to become apparent

When Should You Consider a GLP-1 Agonist

Both included articles showed initial weight loss and a reduction of disease severity following treatment with the GLP-1 agonist, Liraglutide (Table 1)

Conversely, CPA/EE showed a stronger effect to reduce androgens levels (99)
